John Matthew Dubach, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biosensing Techniques | 7 | 2013 | 662 | 0.870 |
Why?
|
Nanotechnology | 5 | 2013 | 714 | 0.730 |
Why?
|
Spectrometry, Fluorescence | 2 | 2014 | 694 | 0.630 |
Why?
|
Fluorescent Dyes | 7 | 2015 | 1933 | 0.590 |
Why?
|
Sodium | 4 | 2013 | 1597 | 0.550 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 266 | 0.410 |
Why?
|
Sodium Compounds | 1 | 2011 | 35 | 0.380 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2433 | 0.350 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1231 | 0.320 |
Why?
|
Hyponatremia | 1 | 2010 | 279 | 0.300 |
Why?
|
Single-Cell Analysis | 2 | 2016 | 2542 | 0.300 |
Why?
|
Metabolome | 1 | 2014 | 1009 | 0.280 |
Why?
|
Microscopy, Fluorescence | 5 | 2017 | 2635 | 0.270 |
Why?
|
Ions | 1 | 2007 | 256 | 0.270 |
Why?
|
Quantum Dots | 1 | 2007 | 168 | 0.250 |
Why?
|
Image Enhancement | 2 | 2014 | 2898 | 0.250 |
Why?
|
Metabolomics | 1 | 2014 | 1675 | 0.240 |
Why?
|
Chloramines | 3 | 2010 | 15 | 0.220 |
Why?
|
Nanoparticles | 3 | 2017 | 1989 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 2 | 2016 | 5707 | 0.210 |
Why?
|
Nanostructures | 1 | 2007 | 553 | 0.200 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2024 | 428 | 0.190 |
Why?
|
Kinetics | 2 | 2024 | 6332 | 0.180 |
Why?
|
Myocytes, Cardiac | 1 | 2009 | 1682 | 0.180 |
Why?
|
Sodium Channels | 2 | 2013 | 341 | 0.170 |
Why?
|
Parietal Cells, Gastric | 2 | 2010 | 39 | 0.160 |
Why?
|
Oxidants | 2 | 2010 | 168 | 0.150 |
Why?
|
Skin | 1 | 2010 | 4506 | 0.140 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2017 | 108 | 0.140 |
Why?
|
Molecular Structure | 2 | 2016 | 1885 | 0.120 |
Why?
|
DNA Damage | 1 | 2024 | 2472 | 0.110 |
Why?
|
Zinc | 2 | 2010 | 677 | 0.110 |
Why?
|
Fibrosarcoma | 1 | 2015 | 313 | 0.110 |
Why?
|
Cations | 2 | 2011 | 240 | 0.100 |
Why?
|
Substrate Specificity | 1 | 2016 | 1751 | 0.100 |
Why?
|
Kidney | 1 | 2007 | 7058 | 0.100 |
Why?
|
Calcium Signaling | 2 | 2007 | 738 | 0.090 |
Why?
|
Ionophores | 1 | 2011 | 108 | 0.090 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3057 | 0.090 |
Why?
|
Microspheres | 1 | 2014 | 789 | 0.090 |
Why?
|
Anisotropy | 1 | 2014 | 1295 | 0.090 |
Why?
|
Microinjections | 1 | 2011 | 322 | 0.090 |
Why?
|
Fluorescence | 2 | 2011 | 757 | 0.090 |
Why?
|
Staining and Labeling | 1 | 2014 | 1081 | 0.090 |
Why?
|
DNA | 1 | 2024 | 7214 | 0.090 |
Why?
|
Drug Design | 1 | 2015 | 1046 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2015 | 752 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2488 | 0.080 |
Why?
|
Methylgalactosides | 1 | 2008 | 3 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6131 | 0.080 |
Why?
|
Sodium Channel Blockers | 1 | 2009 | 173 | 0.080 |
Why?
|
Microscopy, Confocal | 2 | 2017 | 1973 | 0.080 |
Why?
|
Tetrodotoxin | 1 | 2009 | 243 | 0.080 |
Why?
|
Sulfhydryl Compounds | 2 | 2007 | 296 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10765 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1068 | 0.070 |
Why?
|
Gastric Mucosa | 1 | 2010 | 602 | 0.070 |
Why?
|
Patch-Clamp Techniques | 1 | 2009 | 927 | 0.070 |
Why?
|
Molecular Probe Techniques | 1 | 2007 | 111 | 0.070 |
Why?
|
Transducers | 1 | 2007 | 245 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2014 | 1240 | 0.060 |
Why?
|
Biological Transport | 1 | 2009 | 2085 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2007 | 3139 | 0.060 |
Why?
|
Cell Line | 2 | 2009 | 15604 | 0.060 |
Why?
|
Mice, Nude | 1 | 2010 | 3631 | 0.060 |
Why?
|
Animals | 10 | 2017 | 169335 | 0.060 |
Why?
|
Animals, Newborn | 1 | 2009 | 2683 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4076 | 0.050 |
Why?
|
Mice | 5 | 2017 | 82072 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1798 | 0.050 |
Why?
|
Particle Size | 1 | 2007 | 1652 | 0.050 |
Why?
|
Action Potentials | 1 | 2009 | 1838 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5801 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4794 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3538 | 0.040 |
Why?
|
Dithiothreitol | 2 | 2010 | 94 | 0.040 |
Why?
|
Ethylenediamines | 2 | 2010 | 57 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4352 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2011 | 945 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10276 | 0.040 |
Why?
|
Oxidation-Reduction | 3 | 2010 | 2226 | 0.040 |
Why?
|
Colon | 1 | 2005 | 1803 | 0.030 |
Why?
|
Chelating Agents | 2 | 2010 | 385 | 0.030 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 115 | 0.030 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2017 | 187 | 0.030 |
Why?
|
Fura-2 | 2 | 2007 | 107 | 0.030 |
Why?
|
Rats | 2 | 2009 | 23786 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6435 | 0.030 |
Why?
|
Ascorbic Acid | 2 | 2010 | 658 | 0.030 |
Why?
|
Pharmacology | 1 | 2015 | 97 | 0.030 |
Why?
|
Pharmacokinetics | 1 | 2015 | 86 | 0.030 |
Why?
|
Metals, Heavy | 2 | 2007 | 149 | 0.030 |
Why?
|
Humans | 8 | 2024 | 768970 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13698 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 19023 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 580 | 0.030 |
Why?
|
Signal Transduction | 3 | 2017 | 23653 | 0.030 |
Why?
|
Rabbits | 2 | 2010 | 4774 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13594 | 0.020 |
Why?
|
Perfusion | 1 | 2017 | 1402 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14752 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1913 | 0.020 |
Why?
|
Antioxidants | 2 | 2010 | 1673 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1125 | 0.020 |
Why?
|
Polycyclic Compounds | 1 | 2010 | 28 | 0.020 |
Why?
|
Cytoprotection | 1 | 2010 | 200 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2011 | 687 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 818 | 0.020 |
Why?
|
Adhesiveness | 1 | 2008 | 52 | 0.020 |
Why?
|
Buffers | 1 | 2008 | 143 | 0.020 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 162 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3621 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2015 | 826 | 0.020 |
Why?
|
Silicon | 1 | 2008 | 143 | 0.020 |
Why?
|
X-Rays | 1 | 2008 | 311 | 0.020 |
Why?
|
Solvents | 1 | 2008 | 298 | 0.020 |
Why?
|
Calcium-Transporting ATPases | 1 | 2007 | 122 | 0.020 |
Why?
|
Homeostasis | 2 | 2010 | 3347 | 0.020 |
Why?
|
Boronic Acids | 1 | 2010 | 915 | 0.020 |
Why?
|
Albumins | 1 | 2008 | 577 | 0.020 |
Why?
|
Acetylcysteine | 1 | 2007 | 262 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1169 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2005 | 455 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3952 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2008 | 1104 | 0.010 |
Why?
|
Calcium | 2 | 2007 | 5792 | 0.010 |
Why?
|
Light | 1 | 2008 | 1355 | 0.010 |
Why?
|
Cytoplasm | 1 | 2007 | 1505 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1083 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1632 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 17173 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5793 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9527 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9499 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22379 | 0.010 |
Why?
|
Lung | 1 | 2017 | 10099 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40261 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65480 | 0.010 |
Why?
|
Female | 1 | 2017 | 397515 | 0.000 |
Why?
|